49 results on '"León-Peña, Andrés"'
Search Results
2. Non-alcoholic fatty liver disease and thrombocytopenia IV: its association with granulocytopenia
3. Helicobacter pylori antibodies and multiple sclerosis: a single-center study and a short review of the literature
4. Acute Leukemia Characteristics are Different Around the World: the Mexican Perspective
5. Primary Thrombophilia in México XI: Activated Protein C Resistance Phenotypes are Multifactorial
6. OUTCOMES OF PATIENTS REQUIRING TRACHEOSTOMY AFTER DELAYED CHEST CLOSURE FOLLOWING BILATERAL LUNG TRANSPLANTATION
7. A Feasibility Study of the Full Outpatient Conduction of Hematopoietic Transplants in Persons with Multiple Sclerosis Employing Autologous Non-Cryopreserved Peripheral Blood Stem Cells
8. Splitting the Total Dose of Cyclophosphamide in Two Blocks Apart during the Conditioning of Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Results in Diminished Cardiotoxicity: Experience in 1,000 Patients
9. Haploidentical Stem Cell Transplantation Can be Fully Conducted on an Outpatient Basis
10. Outpatient Based Autologous Hematopoietic Stem Cell Transplantation Is a Feasible Therapeutic Option for Patients with Chronic Inflammatory Demyelinating Polyneuropathy: The Mexican Experience
11. Central Venous Access for Peripheral Stem Cell Collection in Autologous Donors: Safety within an Outpatient Transplantation Program
12. Long-term results of the treatment of Hodgkin’s lymphoma in a resource-constrained setting: Real-world data from a single center
13. Mantle cell lymphoma may have a different clinical course in Mexican Mestizos: Real-world data from a single center
14. The 1,000th Transplant for Multiple Sclerosis and Other Autoimmune Disorders at the HSCT-México Program: A Myriad of Experiences and Knowledge
15. Long-Term Results of the Treatment of Persons with Hodgkin's Lymphoma in a Resource-Constrained Setting: Real-World Data from a Single Center
16. Chronic Lymphocytic Leukemia Treatment in México: Up to Half Patients May Not Requiere Treatment
17. Early Response Predicts Long-Term Improvement or Stabilization of Persons with Multiple Sclerosis Treated with Hematopoietic Stem Cell Transplantation
18. 441 - Outpatient Based Autologous Hematopoietic Stem Cell Transplantation Is a Feasible Therapeutic Option for Patients with Chronic Inflammatory Demyelinating Polyneuropathy: The Mexican Experience
19. 342 - Socioeconomic Factors Related to Hematopoietic Stem Cell Transplantation for Autoimmune Disorders in North American and European Patients
20. 326 - Central Venous Access for Peripheral Stem Cell Collection in Autologous Donors: Safety-Related Outcomes of an Outpatient Transplantation Program
21. 302 - Cyclophosphamide Split in Two Blocks Apart Renders an Excellent Cardiac Safety Profile during Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis and Other Autoimmune Disorders
22. Up to half of patients diagnosed with chronic lymphocytic leukemia in México may not require treatment
23. Treatment of Persons with Multiple Myeloma in Underprivileged Circumstances: Real-World Data from a Single Institution
24. Respiratory impairment in persons with multiple sclerosis: A cross-sectional study
25. Quality of Life in Patients with Multiple Sclerosis after Autologous Hematopoietic Stem Cell Transplantation
26. Treatment of Persons with Multiple Myeloma in Underprivileged Circumstances: Real-World Data of a Prospective Study in a Single Institution
27. Primary thrombophilia XV: antithrombotic treatment of sticky platelet syndrome worldwide
28. Determine safety of outpatient chemotherapy and autotransplants using refrigerated, non‐frozen grafts in persons with multiple sclerosis
29. 387 - Prognostic Features in Autografted People with Multiple Sclerosis Using an Outpatient Non-Myeloablative Regimen: Early Response Is Associated with Long-Term Improvement and Stabilization of Disease
30. 388 - Development and Validation of Predictive Models for Transfusions in Hematopoietic Stem Cell Transplants for Autoimmune Disorders
31. Nonalcoholic Fatty Liver Disease and Thrombocytopenia III: Its Association With Insulin Resistance
32. Hematopoietic Stem Cell Transplantation in Persons with Multiple Myeloma in Underprivileged Circumstances: Real-World Data of a Prospective Study in a Single Institution
33. Quality of Life in Patients with Multiple Sclerosis after Autologous Hematopoietic Stem Cell Transplantation
34. Self-Reported Changes in the Expanded Disability Status Scale (EDSS) Score in Persons with Multiple Sclerosis after Autologous Stem Cell Transplants: Experience with the “Mexican Method”
35. Self-Reported Changes in the Expanded Disability Status Scale (EDSS) Score in Persons with Multiple Sclerosis after Autologous Stem Cell Transplants: Experience with the “Mexican Method”
36. Inefficacy of Rituximab Post-Autologous Hematopoietic Stem Cell Transplant to Prevent Relapses in Persons with Multiple Sclerosis
37. Outpatient Autotransplants for Persons with Multiple Sclerosis
38. Primary Thrombophilia in México XI: Activated Protein C Resistance Phenotypes are Multifactorial
39. Primary Thrombophilia in Mexico XII: Miscarriages Are More Frequent in Persons with the Sticky Platelet Syndrome (SPS)
40. a Feasibility Study of the Full Outpatient Conduction of Hematopoietic Transplants in Persons with Multiple Sclerosis Employing Autologous Non-Cryopreserved Peripheral Blood Stem Cells
41. Clearance of donor cell leukemia by means of graft versus leukemia effect: A case report
42. Outpatient Autotransplants for Persons with Multiple Sclerosis
43. Outpatient Hematopoietic Grafting in Patients with Multiple Sclerosis Employing Autologous Non-Cryopreserved Peripheral Blood Stem Cells: A Feasibility Study
44. 159 - A Feasibility Study of the Full Outpatient Conduction of Hematopoietic Transplants in Persons with Multiple Sclerosis Employing Autologous Non-Cryopreserved Peripheral Blood Stem Cells
45. IKAROS Gene Deleted B-Cell Acute Lymphoblastic Leukemia in Mexican Mestizos: Observations in Seven Patients and a Short Review of the Literature.
46. MEXICAN BIOSIMILAR FILGRASTIM FOR AUTOLOGOUS HEMATOPOIETIC STEM CELL MOBILIZATION AND TRANSPLANTATION.
47. Mantle cell lymphoma may have a different clinical course in Mexican Mestizos: Real-world data from a single center.
48. Mexican Biosimilar Filgrastim for Autologous Hematopoietic Stem Cell Mobilization and Transplantation.
49. IKAROS Gene Deleted B-Cell Acute Lymphoblastic Leukemia in Mexican Mestizos: Observations in Seven Patients and a Short Review of the Literature.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.